Muscular Atrophy clinical trials at University of California Health
2 in progress, 0 open to eligible people
Showing trials for
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
Sorry, in progress, not accepting new patients
The ONYX study is an Open-Label, Multicenter, Extension study that will evaluate the long-term safety and efficacy of Apitegromab in Patients with Type 2 and Type 3 SMA who have completed TOPAZ or SAPPHIRE.
at UCSD
IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
Sorry, not currently recruiting here
An open-label dose escalation study to assess the safety and tolerability of IMM01-STEM in participants with muscle atrophy related to knee osteoarthritis
at UC Irvine
Last updated: